Sarah Gheuens - 01 Mar 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Medical Officer
Signature
/s/ William Cook, as attorney-in-fact for Sarah Gheuens
Issuer symbol
AGIO
Transactions as of
01 Mar 2023
Net transactions value
-$28,373
Form type
4
Filing time
03 Mar 2023, 15:05:37 UTC
Previous filing
14 Feb 2023
Next filing
30 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +3,833 +22% $0.000000 21,250 01 Mar 2023 Direct F1
transaction AGIO Common stock Tax liability $28,373 -1,134 -5.3% $25.02 20,116 03 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Award $0 +12,000 $0.000000 12,000 01 Mar 2023 Common stock 12,000 Direct F2, F3
transaction AGIO Stock options (right to buy) Award $0 +44,000 $0.000000 44,000 01 Mar 2023 Common stock 44,000 $25.01 Direct F4
transaction AGIO Restricted stock units Options Exercise $0 -3,833 -33% $0.000000 7,667 01 Mar 2023 Common stock 3,833 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 408 shares purchased through the Company's employee stock purchase plan.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
F4 This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F5 The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.